Brain Monitoring Market: Information by Product (Device), Application (Parkinson’s Disease), End-User (Hospitals), and Region — Forecast till 2029

Table Of Content

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview and Dynamics

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Global Brain Monitoring Market

3.3       Key Market Trends

3.3.1   Drivers

3.3.2   Restraints

3.3.3   Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1   Bargaining Power of Suppliers

3.4.2   Bargaining Power of Buyers

3.4.3   Threat of Substitution

3.4.4   Threat of New Entrants

3.4.5   Competitive Rivalry

3.5       Market Share Analysis

3.6       Technological Landscape

3.7       Impact of COVID-19 on Global Brain Monitoring Market

4          Product Overview

4.1       Introduction

4.1.1   Market Size & Forecast (Value)

4.2       Device

4.2.1   Market Size & Forecast (Value)

4.2.1.1            Computerized Tomography (CT) Scanners

4.2.1.2            Magnetic Resonance Imaging (MRI) Scanners

4.2.1.3            Positron Emission Tomography (PET) Scanners

4.2.1.4            Electroencephalograph (EEG) Devices

4.2.1.5            Electromyography (EMG) Devices

4.2.1.6            Magnetoencephalography (MEG) Devices

4.2.1.7            Transcranial Doppler (TCD) Devices

4.2.1.8            Sleep Monitoring Devices

4.2.1.9            Intracranial Pressure (ICP) Monitors

4.2.1.10 Cerebral Oximeters

4.3       Accessories

4.3.1   Market Size & Forecast (Value)

4.3.1.1            Electrodes

4.3.1.2            Sensors

4.3.1.3            Caps   

4.3.1.4            Pastes & Gels

4.3.1.5            Batteries

4.3.1.6            Others

5          Application Overview

5.1       Introduction

5.1.1   Market Size & Forecast (Value)

5.2       Parkinson’s Disease

5.2.1   Market Size & Forecast (Value)

5.3       Traumatic Brain Injury

5.3.1   Market Size & Forecast (Value)

5.4       Epilepsy

5.4.1   Market Size & Forecast (Value)

5.5       Dementia

5.5.1   Market Size & Forecast (Value)

5.6       Stroke

5.6.1   Market Size & Forecast (Value)

5.7       Other Applications

5.7.1   Market Size & Forecast (Value)

6          End-User Overview

6.1       Introduction

6.1.1   Market Size & Forecast (Value)

6.2       Hospitals

6.2.1   Market Size & Forecast (Value)

6.3       Neurology Centers

6.3.1   Market Size & Forecast (Value)

6.4       Diagnostic Centers

6.4.1   Market Size & Forecast (Value)

6.5       Other End-Users

6.5.1   Market Size & Forecast (Value)

7          Regional Overview

7.1      Introduction

7.1.1   Market Size & Forecast (Value)

7.2      Americas

7.2.1   North America

7.2.1.1      The U.S.

7.2.1.1.1         By Product

7.2.1.1.2         By Application

7.2.1.1.3         By End-User

7.2.1.2      Canada

7.2.1.2.1         By Product

7.2.1.2.2         By Application

7.2.1.2.3         By End-User

7.2.2   South America

7.2.2.1      By Product

7.2.2.2      By Application

7.2.2.3      By End-User

7.3      Europe

7.3.1   Market Size & Forecast (Value)

7.3.2   Western Europe

7.3.2.1      The U.K.

7.3.2.1.1         By Product

7.3.2.1.2         By Application

7.3.2.1.3         By End-User

7.3.2.2      Germany

7.3.2.2.1         By Product

7.3.2.2.2         By Application

7.3.2.2.3         By End-User

7.3.2.3      France

7.3.2.3.1         By Product

7.3.2.3.2         By Application

7.3.2.3.3         By End-User

7.3.2.4      Spain

7.3.2.4.1         By Product

7.3.2.4.2         By Application

7.3.2.4.3         By End-User

7.3.2.5      Italy

7.3.2.5.1         By Product

7.3.2.5.2         By Application

7.3.2.5.3         By End-User

7.3.3   Eastern Europe

7.3.3.1             By Product

7.3.3.2             By Application

7.3.3.3            By End-User

7.3.4   The Rest of Europe

7.3.4.1             By Product

7.3.4.2             By Application

7.3.4.3             By End-User

7.4      Asia-Pacific

7.4.1   Market Size & Forecast (Value)

6.4.2   Japan

7.4.2.1            By Product

7.4.2.2            By Application

7.4.2.3            By End-User

7.4.3   China

7.4.3.1            By Product

7.4.3.2            By Application

7.4.3.3            By End-User

7.4.4   Australia

7.4.4.1            By Product

7.4.4.2            By Application

7.4.4.3            By End-User

7.4.5   India

7.4.5.1            By Product

7.4.5.2            By Application

7.4.5.3            By End-User

7.4.6   South Korea

7.4.6.1            By Product

7.4.6.2            By Application

7.4.6.3            By End-User

7.4.7   The Rest of Asia-Pacific

7.4.7.1            By Product

7.4.7.2            By Application

7.4.7.3            By End-User

9.5      The Middle East and Africa

9.5.1   The Middle East and Africa

9.5.1.1            By Product

9.5.1.2            By Application

9.5.1.3            By End-User

10        Company Profile

10.1    Medtronic Plc.

10.1.1 Company Overview

10.1.2 Financial Performance

10.1.3 Recent Developments

10.1.4 Product Portfolio

10.2    Nihon Kohden Corporation

10.2.1 Company Overview

10.2.2 Financial Performance

10.2.3 Recent Developments

10.2.4 Product Portfolio

10.3    Philips Healthcare

10.3.1 Company Overview

10.3.2 Financial Performance

10.3.3 Recent Developments

10.3.4 Product Portfolio

10.4    GE Healthcare

10.4.1 Company Overview

10.4.2 Financial Performance

10.4.3 Recent Developments

10.4.4 Product Portfolio

10.5    Siemens Healthineers

10.5.1 Company Overview

10.5.2 Financial Performance

10.5.3 Recent Developments

10.5.4 Product Portfolio

10.6    Advanced Brain Monitoring

10.6.1 Company Overview

10.6.2 Financial Performance

10.6.3 Recent Developments

10.6.4 Product Portfolio

10.7    Masimo Corporation

10.7.1 Company Overview

10.7.2 Financial Performance

10.7.3 Recent Developments

10.7.4 Product Portfolio

10.8    NeuroWave Systems Inc.

10.8.1 Company Overview

10.8.2 Financial Performance

10.8.3 Recent Developments

10.8.4 Product Portfolio

10.9    Resmed, Inc.

10.9.1 Company Overview

10.9.2 Financial Performance

10.9.3 Recent Developments

10.9.4 Product Portfolio

10.10  Natus medical Incorporated

10.10.1Company Overview

10.10.2Financial Performance

10.10.3Recent Developments

10.10.4Product Portfolio

11        Conclusion & Recommendations

12        Acronyms & Abbreviations

Report Description Download Sample

Copyright . All rights Reserved By Straits Research